Anda
Sure, here's a detailed MediaWiki source code formatted medical dictionary article for the topic Anda:
```
Anda
Anda is a term used in the medical field, particularly in the area of pharmacology. It refers to a type of generic drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, and performance characteristics.
Overview
The term "Anda" is an acronym for "Abbreviated New Drug Application". This is a submission to the Food and Drug Administration (FDA) for the approval to market a generic drug in the United States. The ANDA process was established by the Hatch-Waxman Act in 1984 to expedite the approval of generic drugs and increase their availability in the market.
Process
The ANDA process involves a rigorous review by the FDA to ensure that the generic drug is bioequivalent to the brand-name drug it is intended to replicate. This means that the generic drug must deliver the same amount of active ingredients into a patient's bloodstream in the same amount of time as the original brand-name drug.
Importance
The ANDA process is crucial in the pharmaceutical industry as it allows for the production and distribution of affordable, generic versions of brand-name drugs. This not only increases access to necessary medications for patients but also promotes competition in the industry, which can lead to lower drug prices overall.
See Also
External links
- Medical encyclopedia article on Anda
- Wikipedia's article - Anda
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
```
This article provides a brief overview of Anda, its meaning, the process involved, and its importance in the medical field. It also includes internal links to related topics for further reading.